Compare Quantumscape Corp (QS) vs Vir Biotechnology Inc. Common Stock (VIR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Quantumscape Corp vs Vir Biotechnology Inc. Common Stock — how do they compare? Quantumscape Corp trades at $3.94 (market cap $2.43B), while Vir Biotechnology Inc. Common Stock trades at $10.51 (market cap $1.76B). The key difference: Quantumscape Corp is the larger of the two by market cap, and Vir Biotechnology Inc. Common Stock is trading nearer its 52-week high, Quantumscape Corp nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Quantumscape Corp for 37 Days and Vir Biotechnology Inc. Common Stock for 0 Days on average.
| QS | VIR | |
|---|---|---|
Market Cap | $2.43B | $1.76B |
Volume | 14,407,354 | 2,764,948 |
Sector | Consumer Cyclical | Health |
52-Week High | $18.44 | $11.78 |
52-Week Low | $3.93 | $5.12 |
Typical Hold Time | 37 Days | 0 Days |
Enterprise Value | $1.64B | $1.32B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
QuantumScape trades at $4.12, down 3.51% on the day, as the solid-state battery developer continues to face commercialization delays and negative profitability. The stock shows bearish technical signals with mixed oscillators, while fundamental metrics reveal significant challenges including zero revenue, negative $435.05M net income for 2025, and negative ROE of -39.08%. Recent news highlights insider selling and competitive pressures in the EV battery space.
The outlook remains challenging with commercialization not expected until 2029, creating substantial execution risk. While the consensus price target of $10.35 suggests potential upside, the lack of revenue and persistent cash burn present significant hurdles. Investment opportunity exists only for patient investors willing to accept high risk for potential breakthrough technology rewards.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Quantumscape Corp
QuantumScape Corp is engaged in the development of next-generation solid-state lithium-metal batteries for use in electric vehicles. It developed anode-less cell design, which delivers high energy density while lowering material costs and simplifying manufacturing.
Read more on QS →About Vir Biotechnology Inc. Common Stock
Vir Biotechnology, Inc. is a US clinical-stage biopharmaceutical company that develops monoclonal antibody-based medicines to treat and prevent serious infectious diseases.
Read more on VIR →
